The October 5 announcement of the 2020 Nobel Prize in medicine. Image by JONATHAN NACKSTRAND/Getty Images

(JTA) — The Nobel Prize in medicine was awarded to three scientists who identified the hepatitis C virus.

The prize was awarded Monday to Harvey Alter of the National Institutes of Health, Michael Houghton of the University of Alberta, and Charles Rice of Rockefeller University.

“The Nobel Laureates’ discovery of Hepatitis C virus is a landmark achievement in the ongoing battle against viral diseases. Thanks to their discovery, highly sensitive blood tests for the virus are now available and these have essentially eliminated post-transfusion hepatitis in many parts of the world, greatly improving global health,” the Nobel committee said in announcing the prize.

Forwarding the News

Thoughtful, balanced reporting from the Forward and around the web, bringing you updated news and analysis each day.

Terms(Required)

I agree to the Forward's Terms of Service and Privacy Policy

Email(Required)

Alter, 85, who is Jewish, was born in New York and attended medical school at the University of Rochester. Early in his career he worked with the Nobel Prize-winning scientist Baruch Blumberg, who identified the hepatitis B virus.

In 2000, he received the Albert Lasker Award for Clinical Medical Research for his work leading to the discovery of the virus that causes hepatitis C.

Houghton isolated the genetic sequence of the new hepatitis C virus while working at Chiron Corporation in the 1980s. Rice showed that hepatitis C virus alone could cause hepatitis.

The post Jewish researcher shares Nobel Prize in medicine for identifying hepatitis C virus appeared first on Jewish Telegraphic Agency.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

The coming year promises to be filled with more complex and historic developments. We are entering an era where independent, fact-based Jewish journalism will be more important than ever. We need to be ready for whatever 2025 will bring, and with your help, we can be.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

$36 $500

$120 $180 Other amount